Publication | Closed Access

KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases

Surgical OncologyHepatologyInternational Genetic ConsortiumGastrointestinal OncologyMedicineHepatobiliary TumorPathologyLiver DiseaseLiver MetastasesLiver CancerPre-hepatectomy ChemotherapyOncologyRadiation Oncology